Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Child Abuse Negl ; : 106863, 2024 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-38816302

RESUMEN

BACKGROUND: Child maltreatment is a pressing public health concern that poses long-lasting health and economic impacts on children and society. While several preventive interventions have demonstrated their effectiveness in reducing the occurrence of child maltreatment and its associated economic impacts, the cost-effectiveness of such interventions remains unclear. OBJECTIVE: This study aims to provide a comprehensive overview and a narrative synthesis of the available economic evidence on child maltreatment preventive interventions in both high-income and low-middle-income countries. METHOD: Systematic searches were conducted in MEDLINE, PsycINFO, Embase, CINAHL, Web of Science, and Econlit to identify full economic evaluations and return-on-investment studies on child maltreatment preventive interventions. The methodological quality of eligible studies was assessed using Drummond's 10-point checklist. This review adhered to the PRISMA guidelines, and summarized findings in a narrative synthesis. RESULTS: Twenty-six studies met the inclusion criteria. Of these, eight evaluated home visiting, four evaluated early childhood education (ECE), four assessed multi-component (MC), and three examined group-based parent education (GPE) interventions. The remaining studies assessed interventions to prevent abusive head trauma (AHT; n = 2), child sexual abuse (n = 2), physical abuse at school (n = 1), as well as individualized intensive parenting (IIP; n = 2), and counseling (n = 1) interventions. Two studies were conducted in low-middle-income countries, while the others were all in high-income countries. CONCLUSIONS: The included studies generally exhibited high methodological quality. Only AHT, ECE, IIP, and MC interventions demonstrated promising cost-effectiveness credentials in preventing child maltreatment. More economic evaluations are needed for interventions with mixed findings (e.g. GPE) and in low-middle-income countries.

2.
Int J Eat Disord ; 57(2): 265-285, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38111296

RESUMEN

OBJECTIVE: This systematic review updates an existing review examining the cost-effectiveness of interventions to prevent and treat eating disorders (EDs). METHOD: Literature search was conducted in Academic Search Complete, MEDLINE, CINAHL, PsycINFO, EconLit, Global Health, ERIC, Health Business Elite, and Health Policy Reference Center electronic databases, capturing studies published between March 2017 to April 2023. Hand-searching was conducted as supplementary including gray literature search. Included articles were (1) full economic evaluations or return-on-investment studies, (2) in English and (3) aimed at prevention and treatment of any ED. Included studies were added and synthesized with previously reviewed studies. Screening and extraction followed PRISMA guidelines. Quality assessment was conducted using the Drummond checklist. PROSPERO registration CRD42021287464. RESULTS: A total of 28 studies were identified, including 15 published after the previous review. There were nine prevention, seven anorexia nervosa (AN) treatment, five bulimia nervosa (BN) treatment, four binge-eating disorder (BED), and three non-specific ED treatment studies. Findings indicate value-for-money evidence supporting all interventions. Quality assessment showed studies were fair-to-good quality. DISCUSSION: There has been significant growth in cost-effectiveness studies over the last 5 years. Findings suggest that interventions to prevent and treat ED offer value for money. Interventions such as Featback (ED prevention and non-specific ED treatment); focal psychodynamic therapy, enhanced cognitive behavioral therapy, and high-calorie refeeding (AN treatment); stepped-care with assisted self-help and internet-based cognitive behavioral therapy (BN treatment); and cognitive behavioral therapy guided self-help intervention (BED treatment) have good quality economic evidence. Further research in implementation of interventions is required. PUBLIC SIGNIFICANCE STATEMENT: The increasing prevalence of ED globally has significant impact on healthcare systems, families, and society. This review is showcasing the value for money of interventions of eating disorders prevention and treatment. This review found that existing interventions offers positive economic benefit for the healthcare system.


OBJETIVO: Esta revisión sistemática actualiza una revisión existente que examina la rentabilidad de las intervenciones para prevenir y tratar los trastornos de la conducta alimentaria (TCA). MÉTODO: Se realizó una búsqueda bibliográfica en las bases de datos electrónicas Academic Search Complete, MEDLINE, CINAHL, PsycINFO, EconLit, Global Health, ERIC, Health Business Elite y Health Policy Reference Center, abarcando estudios publicados entre marzo de 2017 y abril de 2023. Se realizó una búsqueda manual como complemento, incluyendo la búsqueda de literatura gris. Los artículos incluidos eran (1) evaluaciones económicas completas o estudios de retorno de inversión, (2) en inglés y (3) dirigidos a la prevención y tratamiento de cualquier TCA. Los estudios incluidos se añadieron y sintetizaron con estudios previamente revisados. El cribado y la extracción siguieron las pautas PRISMA. La evaluación de la calidad se realizó utilizando la lista de verificación de Drummond. Registro en PROSPERO CRD42021287464. RESULTADOS: Se identificaron 28 estudios, incluyendo 15 publicados después de la revisión anterior. Hubo nueve estudios de prevención, siete de tratamiento de anorexia nerviosa (AN), cinco de tratamiento de bulimia nerviosa (BN), cuatro de trastorno por atracón (TpA) y tres de tratamiento de TCA no especificados. Los hallazgos indican evidencia de valor por dinero que respalda todas las intervenciones. La evaluación de la calidad mostró que los estudios eran de calidad aceptable a buena. DISCUSIÓN: Ha habido un crecimiento significativo en los estudios de rentabilidad en los últimos cinco años. Los hallazgos sugieren que las intervenciones para prevenir y tratar los TCA ofrecen valor por dinero. Intervenciones como Featback (prevención de TCA y tratamiento de TCA no específicos); terapia psicodinámica focal, terapia cognitivo-conductual mejorada y rehabilitación nutricional con alto contenido calórico (tratamiento de AN); atención escalonada con autoayuda asistida y terapia cognitivo-conductual en línea (tratamiento de BN); y terapia cognitivo-conductual guiada de autoayuda (tratamiento de TpA) tienen una buena evidencia económica de calidad. Se requiere más investigación en la implementación de intervenciones.


Asunto(s)
Anorexia Nerviosa , Trastorno por Atracón , Bulimia Nerviosa , Terapia Cognitivo-Conductual , Trastornos de Alimentación y de la Ingestión de Alimentos , Humanos , Trastornos de Alimentación y de la Ingestión de Alimentos/diagnóstico , Trastornos de Alimentación y de la Ingestión de Alimentos/prevención & control , Bulimia Nerviosa/psicología , Trastorno por Atracón/psicología , Anorexia Nerviosa/terapia , Análisis Costo-Beneficio
3.
Molecules ; 28(15)2023 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-37570892

RESUMEN

Coffee pulp is an abundant residue from the coffee industry, but it still contains large amounts of valuable compounds such as polyphenols. The extraction of polyphenols from coffee pulp by the conventional method is accompanied by contaminated compounds. This study, therefore, applied an aqueous two-phase system consisting of different ratios of ethanol/ammonium sulfate to eliminate impurities from coffee-pulp crude extract. The purification efficiency was evaluated via total polyphenol content, antioxidant activity and two major polyphenols in coffee pulps including chlorogenic acid and caffeic acid. Results showed that phenolic compounds mostly predominated in the alcohol-rich phase in which the antioxidant activity was greatly increased after the purification process. Compared to un-purified crude-coffee extract, the antioxidant activity of the purified samples increased approximately 34%, which was assumed to occur due to the slight increase of chlorogenic acid and caffeic acid. Fourier-transform infrared spectroscopy supported the effectiveness of the purification process by eliminating some impurities.


Asunto(s)
Ácido Clorogénico , Polifenoles , Antioxidantes/farmacología , Ácidos Cafeicos , Extractos Vegetales/química , Etanol
4.
J Pak Med Assoc ; 69(Suppl 2)(6): S49-S56, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31369534

RESUMEN

OBJECTIVE: Health-related quality of life is an important factor when assessing the impairment of a disease and the benefit of treatment, especially eczema-a chronic dermatologic condition. The objective of this study is to express the distinction between quality of life and clinical characteristics of Vietnamese eczema patients pre- and posttreatment by using repeated measurement. METHODS: A before-and-after, prevalence-based study was conducted with a minimum sample size of 132 patients in a dermatology hospital in southern Vietnam. Two domains of SCORAD were applied to demonstrate clinical characteristics while DLQI and EQ-5D-5L were used to identify the impact on patients' quality of life. The difference and correlation between variables were used to express the benefit of treatment through the bootstrapping method, the Spearman test, and multivariable regression. RESULTS: A total of 136 respondents were eligible for this study design, with an average age of 36.9}15.9. The effect of eczema on participants' quality of life was demonstrated through a DLQI mean score of 7.0 (6.2-7.8). There was a correlation between clinical factors, DLQI, and EQ-5D results (p-value < 0.01). After the post-treatment evaluation, the DLQI score decreased by 3.7 points, and a multivariable model reflected the effect levels of symptoms on patient improvement. CONCLUSIONS: Eczema led to a negative effect on patients in many aspects of their lives. Reducing subjective symptoms significantly enhances the quality of life of eczema patients.


Asunto(s)
Dermatitis Atópica/fisiopatología , Calidad de Vida , Adulto , Estudios Transversales , Dermatitis Atópica/terapia , Eccema/fisiopatología , Eccema/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Vietnam , Adulto Joven
5.
J Pak Med Assoc ; 69(Suppl 2)(6): S57-S63, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31369535

RESUMEN

OBJECTIVE: Eczema, a chronic dermatologic disease, has been recognized as an economic burden in publications all over the word but only minimally as such in Vietnam. The aim of this prospective study was to quantify the financial hardships and impairments suffered by eczema patients. METHODS: This cross-sectional prevalence-based study involved 136 patients, whose conditions were classified into three severity levels on the basis of the medications that they were prescribed. Prescription therapy was administered for a month, after which there was patient-oriented assessment of effectiveness. The work productivity and activity impairment (WPAI) questionnaire was used to evaluate productivity loss, which was expressed in percentage form. Bootstrapping was conducted to determine continuous variables and demographybased differences in cost values among the patient groups. RESULTS: For the month-long treatment, each eczema patient needed an average of US$68.1 (range: US$56.2- US$81.5) with the highest proportion being spent on cosmetic treatments. There is noticeable difference between groups among which patients' symptoms demonstrated in distinct levels. The estimates indicated that eczema resulted in 27.8% and 23.1% impairments in work and daily activities, respectively. CONCLUSIONS: The aggravation of disease symptoms can increase the direct costs borne by eczema patients. A decrease in productivity, which is one of the most serious consequences of the condition, should be paid adequate attention to minimize burdens to society.


Asunto(s)
Dermatitis Atópica/economía , Eficiencia , Rendimiento Laboral/economía , Absentismo , Corticoesteroides/economía , Corticoesteroides/uso terapéutico , Adulto , Anciano , Inhibidores de la Calcineurina/economía , Inhibidores de la Calcineurina/uso terapéutico , Cosméticos/economía , Cosméticos/uso terapéutico , Estudios Transversales , Dermatitis Atópica/terapia , Fármacos Dermatológicos/economía , Fármacos Dermatológicos/uso terapéutico , Suplementos Dietéticos/economía , Costos de los Medicamentos , Emolientes/economía , Emolientes/uso terapéutico , Femenino , Estudios de Seguimiento , Costos de la Atención en Salud , Antagonistas de los Receptores Histamínicos/economía , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Cuidados de la Piel , Vietnam
6.
J Pak Med Assoc ; 69(Suppl 2)(6): S87-S95, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31369539

RESUMEN

OBJECTIVE: After surviving from an acute phase of stroke, it is essential for stroke survivors to continue therapies to improve their function and quality of life. The aim of this study was to assess the influence of rehabilitation treatment on the society in economic aspect with evidence from a traditional hospital. METHODS: A prospective cohort study was carried out with patients who were being treated at Traditional Medicine Hospital in Ho Chi Minh City after experiencing a stroke. Patients' relevant medical information was extracted from the hospital's database and placed on a structured questionnaire. RESULTS: Among 103 eligible patients aged 60.3 } 11.4 years, 93.2% had experienced a stroke for the first time. Eighty-four patients were diagnosed with ischaemic stroke, while the number of haemorrhagic stroke patients was approximately 4.5 times lower (n = 19). The mean total cost was $3,310.40 USD, which included $1,653.60 USD, $539.90 USD and $1,117.00 USD for direct medical, direct non-medical and indirect cost, respectively. Hospital bed costs accounted for a considerable percentage of direct medical costs (41.0%). CONCLUSIONS: Stroke was determined to be a significant social burden, although patients in this study had already suffered from the acute phase. This study gives decision makers a comparative view about the economic view on the economic burden of the stroke rehabilitation treatment between using traditional national Western and Eastern therapy.


Asunto(s)
Costos de la Atención en Salud , Hospitalización/economía , Rehabilitación de Accidente Cerebrovascular/economía , Accidente Cerebrovascular/economía , Anciano , Femenino , Hospitales Públicos , Humanos , Masculino , Persona de Mediana Edad , Accidente Cerebrovascular/terapia , Vietnam
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA